← Open Payments lookup

EMILY HEALY: Open Payments

NPI 1669144820 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$392 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $549 · 2025 $392

Food & beverage: $392
CompanyPaymentsAmount
ABBVIE INC.4$94
Neurocrine BioSciences, Inc.3$86
Alkermes, Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$32
Janssen Pharmaceuticals, Inc1$28
Indivior Inc.1$26
E.R. Squibb & Sons, L.L.C.1$25
Takeda Pharmaceuticals U.S.A., Inc.1$19
Teva Pharmaceuticals USA, Inc.1$18
Vanda Pharmaceuticals Inc.1$18

Products named: VRAYLAR, INGREZZA, ARISTADA, CAPLYTA, INVEGA SUSTENNA, SUBLOCADE, COBENFY, TRINTELLIX.

Industry payments across AZ — which companies pay providers there.